CCL5, a ligand of CCR5, is a product of cancer itself and its microenvironment, using the mTOR pathway through the regulation of cyclin D1, c-Myc, and Dad-1 expression to enhance tumor growth [25]. The gene discussed is MTOR; the disease is neoplasm.